From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

How is Haleon - the spin-off from GSK plc - doing, punk?

By Chris Bailey of Financial Orbit | Saturday 12 November 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As per analytical data from my personal pension fund account, I have made money from my choice to retain a holding in Haleon (HLN) - “a global leader 100% focused on consumer healthcare with a competitive advantage to combine deep human understanding with trusted science” - after its spin-off from GSK plc (GSK) in July.  I am not sure that is technically correct given the company’s c. 276.53p share price at the close of business on Friday.  Anyhow, the bigger question is what should I do now?  After all, other GSK shareholders - including Tom - decided to exit stage left kicking around a 300 pence share price immediately after the spin-off and invest elsewhere.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

WIX

How is Wickes getting along?

Friday »

TERN

Tern – Is There More Bad News On The Way?

Thursday »

ZYT

Zytronic – now a recovery Buy?

 

YGEN

Buy Yourgene - target 0.6p

 

ROO

Keep avoiding Deliveroo shares

Friday »

THS

Tharisa – Q1 report, still a value Buy

 

SBRY

Sainsbury’s has a good Christmas